@article{5bf26936939d4881a8312b9185733a04,
title = "First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?",
keywords = "angiogenesis, bevacizumab, EGFR, erlotinib, NSCLC, TKI, tyrosine kinase inhibitor",
author = "Antonio Passaro and Gianluca Spitaleri and {de Marinis}, Filippo",
year = "2016",
month = jul,
day = "16",
doi = "10.1080/14737140.2016.1210007",
language = "English",
pages = "1--3",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
}